Formulation science
Bringing the active ingredient, tablet design, and intended administration together.
RITe™ Platform
RITe™ is our proprietary tablet technology, designed to support rapid drug delivery across a range of active ingredients. Engineered to make medicines easier to take and adaptable to the people who need them, its structure disintegrates in roughly five seconds, creating new possibilities for how medicines are delivered.
THE TABLET
RITe™ tablets disintegrate in roughly 5 seconds. No water is required, and there is no pill to swallow or liquid dose to measure.
Each RITe™ formulation brings the active ingredient, intended delivery route, and needs of the patient together in a small, easy-to-take tablet.


EVERYDAY CONSIDERATIONS
When people need relief, taking medicine should be straightforward. RITe™ combines a defined dose with rapid disintegration, without the need for water, liquid measuring, or swallowing a pill.
We consider the experience of taking medicine alongside the science of the medicine itself: from the tablet’s form to its intended application.
THE DELIVERY APPROACH
For buccal delivery, the tablet disintegrates into a soft, adhesive gel designed to remain against the inner cheek. This contact supports the passage of the medicine through the oral mucosa.
RITe™ (Rapid Infusion Technology™) brings this approach into a tablet that is simple to take.
Each formulation is tailored to its medicine and intended population. Adhesion can be adjusted to maintain contact with the oral mucosa for buccal uptake, or to allow it to disintegrate and be swallowed as a conventional orally disintegrating tablet.
FROM FORMULATION TO MEDICINE
In-house formulation, analytical development, and manufacturing capabilities support the medicines we are developing with RITe™.
Bringing the active ingredient, tablet design, and intended administration together.
Characterizing the attributes that define each formulation.
Building processes to support our investigational medicines.